You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

IDAMYCIN PFS Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Idamycin Pfs patents expire, and what generic alternatives are available?

Idamycin Pfs is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in IDAMYCIN PFS is idarubicin hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Idamycin Pfs

A generic version of IDAMYCIN PFS was approved as idarubicin hydrochloride by MEITHEAL on May 1st, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for IDAMYCIN PFS?
  • What are the global sales for IDAMYCIN PFS?
  • What is Average Wholesale Price for IDAMYCIN PFS?
Summary for IDAMYCIN PFS
Drug patent expirations by year for IDAMYCIN PFS
Drug Prices for IDAMYCIN PFS

See drug prices for IDAMYCIN PFS

Recent Clinical Trials for IDAMYCIN PFS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Guangzhou First People's HospitalPhase 2/Phase 3
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2/Phase 3
The First Affiliated Hospital of Guangzhou Medical UniversityPhase 2/Phase 3

See all IDAMYCIN PFS clinical trials

Pharmacology for IDAMYCIN PFS

US Patents and Regulatory Information for IDAMYCIN PFS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer IDAMYCIN PFS idarubicin hydrochloride INJECTABLE;INJECTION 050734-001 Feb 17, 1997 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.